Animal models of vascular dementia: Translational potential at the present time and in 2050

Future Neurology

Volumn 9, Issue 2, 2014, Pages 163-172

  Tomimoto, Hidekazu ^a   Wakita, Hideaki ^b  

^a MIE UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; lacunar infarction; subcortical ischemic vascular dementia; white matter lesions

Indexed keywords

AGING; ALZHEIMER DISEASE; BILATERAL CAROTID ARTERY STENOSIS; BLEEDING; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN RADIOGRAPHY; CLINICAL FEATURE; EXPERIMENTAL ANIMAL; FUNCTIONAL ANATOMY; GENE MUTATION; GERBIL MODEL; LACUNAR STROKE; MEMORY; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NONHUMAN; PERFUSION; PRIMATE MODEL; PRIORITY JOURNAL; RAT MODEL; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCORTICAL ISCHEMIC VASCULAR DEMENTIA; WHITE MATTER LESION;

EID: 84895810055     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.13.71     Document Type: Review

References (87)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9(7), 689-701 (2010).
2. Erkinjuntti T, Inzitari D, Pantoni L et al. Research criteria for subcortical vascular dementia in clinical trials. J. Neural Transm. Suppl. 59, 23-30 (2000).
3. Bink DI, Ritz K, Aronica E et al. Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J. Cereb. Blood Flow Metab. 33(11), 1666-1684 (2013).
4. Yamori Y, Horie R, Handa H et al. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7(1), 46-53 (1976).
5. Kim S, Hosoi M, Shimamoto K et al. Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension. Biochem. Biophys. Res. Commun. 178(1), 151-157 (1991).
6. Fredriksson K, Auer RN, Kalimo H et al. Cerebrovascular lesions in stroke-prone spontaneously hypertensive rats. Acta Neuropathol. (Berl.) 68, 284-294 (1985).
7. Tagami M, Nara Y, Kubota A et al. Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. Stroke 18(4), 733-740 (1987).
8. Ogata J, Fujishima M, Tamaki K et al. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol. 51(3), 179-184 (1980).
9. Yamori Y, Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 8(4), 456-461 (1977).
10. Yamaguchi M, Sugimachi K, Nakano K et al. Memory deficit accompanying cerebral neurodegeneration after stroke in stroke-prone spontaneously hypertensive rats (SHRSP). Acta Neurochir. Suppl. (Wien) 60, 200-202 (1994).
11. Togashi H, Kimura S, Matsumoto M et al. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke 27(3), 520-525 (1996).
12. Tayebati SK, Tomassoni D, Amenta F. Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior. J. Neurol. Sci. 322(1-2), 241-249 (2012).
13. Sironi L, Guerrini U, Tremoli E et al. Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J. Neurosci. Res. 78, 115-122 (2004b).
14. Lin JX, Tomimoto H, Akiguchi I et al. White matter lesions and alteration of vascular cell composition in the brain of spontaneously hypertensive rats. Neuroreport 12(9), 1835-1839 (2001).
15. Fujita Y, Lin JX, Takahashi R et al. Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Res. 1203, 170-176 (2008).
16. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J. Cereb. Blood Flow Metab. 28(12), 1877-1891 (2008).
17. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 27(9), 1641-1646 (1996).
18. Fernando MS, Simpson JE, Matthews F et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37(6), 1391-1398 (2006).
19. Kudo T, Tada K, Takeda M et al. Learning impairment and microtubule-associated protein 2 decrease in gerbils under chronic cerebral hypoperfusion. Stroke 21(8), 1205-1209 (1990).
20. Hattori H, M. Takeda M, Kudo T et al. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion. Acta Neuropathol. 84(4), 437-442 (1992).
21. Kurumatani T, Kudo T, Ikura Y et al. White matter changes in the gerbil brain under chronic cerebral hypoperfusion. Stroke 29(5), 1058-1062 (1998).
22. Tsuchiya M, Sako K, Yura S et al. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp. Brain Res. 89(1), 87-92 (1992).
23. Tomimoto H, Akiguchi I, Wakita H et al. White matter lesions after occlusion of the bilateral carotid arteries in the rat - temporal profile of cerebral blood flow (CBF), oligodendroglia and myelin. No To Shinkei 49(7), 639-644 (1997).
24. Wakita H, Tomimoto H, Akiguchi I et al. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol. 87(5), 484-492 (1994).
25. Ueno M, Tomimoto H, Akiguchi I et al. Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J. Cereb. Blood Flow Metab. 22(1), 97-104 (2002).
26. Wakita H, Tomimoto H, Akiguchi I et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 924(1), 63-70 (2002).
27. Suenaga T, Ohnishi K, Nishimura M et al. Bundles of amyloid precursor protein-immunoreactive axons in human cerebrovascular white matter lesions. Acta Neuropathol. 87(5), 450-455 (1994).
28. Ohta H, Nishikawa H, Kimura H et al. Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neuroscience 79(4), 1039-1050 (1997).
29. Pappas BA, de la Torre JC, Davidson CM et al. Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction. Brain Res. 708(1-2), 50-58 (1996).
30. Ulrich PT, Kroppenstedt S, Heimann A et al. Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats. Stroke 29(11), 2412-2420(1998).
31. Bennett SA, Tenniswood M, Chen JH et al. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment. Neuroreport 9(1), 161-166 (1998).
32. Sarti C, Pantoni L, Bartolini L et al. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J. Neurol. Sci. 203-204, 263-266 (2002).
33. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res. 673(2), 290-296 (1995).
34. Ouchi Y, Tsukada H, Kakiuchi T et al. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J. Nucl. Med. 39(1), 198-202(1998).
35. Payan HM, Levine S, Strebel R. Effects of cerebral ischemia in various strains of rats. Proc. Soc. Exp. Biol. Med. 120, 208-209 (1965).
36. Kitamura A, Fujita Y, Oishi N et al. Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol. Aging 33(5), 1012.e25-35 (2012).
37. Kitagawa K, Matsumoto M, Yang G et al. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J. Cereb. Blood Flow Metab. 18(5), 570-579 (1998).
38. Shibata M, Ohtani R, Ihara M et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35(11), 2598-2603 (2004).
39. Shibata M, Yamasaki N, Miyakawa T et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38(10), 2826-2832 (2007).
40. Ihara M, Tomimoto H. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J. Aging Res. 2011, 978761 (2011).
41. Nishio K, Ihara M, Yamasaki N et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke 41(6), 1278-1284 (2010).
42. Sood RR, Taheri S, Candelario-Jalil E et al. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J. Cereb. Blood Flow Metab. 28(2), 431-438 (2008).
43. Ihara M, Tomimoto H, Kinoshita M et al. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J. Cereb. Blood Flow Metab. 21(7), 828-834 (2001).
44. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 120(3), 287-296 (2010).
45. Yamada M, Ihara M, Okamoto Y et al. The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PLoS ONE 6(1), e16567 (2011).
46. Kitaguchi, Tomimoto H, Ihara M et al. Chronic cerebral hypoperfusion accelerates amyloid b deposition in APPSwInd transgenic mice. Brain Res. 1294, 202-210 (2009).
47. Okamoto Y, Yamamoto T, Kalaria RN et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 123(3), 381-394 (2012).
48. Shindo A, Yata K, Sasaki R et al. Chronic cerebral ischemia induces redistribution and abnormal phosphorylation of transactivation-responsive DNA-binding protein-43 in mice. Brain Res. 1533, 131-140 (2013).
49. Yoshizaki K, Adachi K, Kataoka S et al. Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp. Neurol. 210(2), 585-591 (2008).
50. Wallays G, Nuyens D, Silasi-Mansat R et al. Notch3 Arg170Cys knock-in mice display pathologic and clinical features of the neurovascular disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arterioscler. Thromb. Vasc. Biol. 31(12), 2881-2888 (2011).
51. Joutel A, Monet-Leprêtre M, Gosele C et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J. Clin. Invest. 120(2), 433-445 (2010).
52. Joutel A. Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays 33(1), 73-80 (2011).
53. Araya R, Noguchi T, Yuhki M et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol. Dis. 24(2), 334-344 (2006).
54. Gould DB, Phalan FC, van Mil SE et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N. Engl. J. Med. 354(14), 1489-1496 (2006).
55. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41(1), 50-55 (2003).
56. Iida S, Baumbach GL, Lavoie JL et al. Spontaneous stroke in a genetic model of hypertension in mice. Stroke 36(6), 1253-1258 (2005).
57. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 16(1), 40-54(2006).
58. Kemper TL, Blatt GJ, Killiany RJ et al. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol. 101(2), 145-153 (2001).
59. Moore TL, Killiany RJ, Rosene DL et al. Impairment of executive function induced by hypertension in the rhesus monkey (Macaca mulatta). Behav. Neurosci. 116(3), 387-396 (2002).
60. Moss MB, Jonak E. Cerebrovascular disease and dementia: a primate model of hypertension and cognition. Alzheimers Dement. 3(2 Suppl.), S6-S15 (2007).
61. Miyamoto N, Pham LD, Hayakawa K et al. Age-related decline in oligodendrogenesis retards white matter repair in mice. Stroke 44(9), 2573-2578 (2013).
62. Arai K, Lo EH. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J. Neurosci. 29(14), 4351-4355 (2009).
63. Tomimoto H, Ihara M, Wakita H et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol. 106(6), 527-534 (2003).
64. Mandai K, Matsumoto M, Kitagawa K et al. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience 77(3), 849-861 (1997).
65. Nakaji K, Ihara M, Takahashi C et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke 37(11), 2816-2823 (2006).
66. Wakita H, Tomimoto H, Akiguchi I et al. Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion. Stroke 26(8), 1415-1422 (1995).
67. Wakita H, Tomimoto H, Akiguchi I et al. Dose dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res. 792(1), 105-113 (1998).
68. Cho KO, La HO, Cho YJ et al. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J. Neurosci. Res. 83(2), 285-291 (2006).
69. Institoris A, Farkas E, Berczi S et al. Effects of cyclooxygenase (COX) inhibition on memory impairment and hippocampal damage in the early period of cerebral hypoperfusion in rats. Eur. J. Pharmacol. 574(1), 29-38 (2007).
70. Wakita H, Ruetzler C, Illoh KO et al. Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. J. Cereb. Blood Flow Metab. 28(2), 341-353 (2008).
71. Ueno Y, Zhang N, Miyamoto N et al. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model. Neuroscience 162(2), 317-327 (2009).
72. Narantuya D, Nagai A, Sheikh AM et al. Microglia transplantation attenuates white matter injury in rat chronic ischemia model via matrix metalloproteinase-2 inhibition. Brain Res. 1316, 145-152 (2010).
73. Fujita Y, Ihara M, Ushiki T et al. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke 41(12), 2938-2943(2010).
74. Miyamoto N, Tanaka R, Zhang N et al. Crucial role for Ser133-phosphorylated form of cyclic AMP-responsive element binding protein signaling in the differentiation and survival of neural progenitors under chronic cerebral hypoperfusion. Neuroscience 162(2), 525-536 (2009).
75. Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J. Mol. Med. (Berl.) 86(6), 715-722 (2008).
76. Kumaran D, Udayabanu M, Kumar M et al. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience 155(3), 626-639 (2008).
77. Washida K, Ihara M, Nishio K et al. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator- activated receptor-g activation in mice with chronic cerebral hypoperfusion. Stroke 41(8), 1798-1806 (2010).
78. Dong YF, Kataoka K, Toyama K et al. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension 58(4), 635-642 (2011).
79. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30(12), 2752-2758 (1999).
80. Carotenuto A, Rea R, Colucci L et al. Late and early onset dementia: what is the role of vascular factors? A retrospective study. J. Neurol. Sci. 322(1-2), 170-175 (2012).
81. Snowdon DA, Greiner LH, Mortimer JA et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 277(10), 813-817 (1997).
82. Petrovitch H, Ross GW, Steinhorn SC et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann. Neurol. 57(1), 98-103 (2005).
83. Matsui Y, Tanizaki Y, Arima H et al. Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J. Neurol. Neurosurg. Psychiatry 80(4), 366-370 (2009).
84. Schley D, Carare-Nnadi R, Please CP et al. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol. 238(4), 962-974 (2006).
85. Thal DR, Ghebremedhin E, Orantes M et al. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/ lipohyalinosis with cognitive decline. J. Neuropathol. Exp. Neurol. 62(12), 1287-1301 (2003).
86. Wardlaw JM, Smith EE, Biessels GJ et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12(8), 822-838 (2013).
87. Taheri S, Gasparovic C, Huisa BN et al. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42(8), 2158-2163 (2011).